Table 5.
Sensitivity, specificity, PPV, and NPV of TCRγδ analysis, heteroduplex analysis, and gene scanning analysis in 17 patients with γδ TCL and 11 patients with reactively higher CD4 and CD8 double-negative ratio.
Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|
TCR Vδ panel | 100% (17/17) | 100% (11/11) | 100% (17/17) | 100% (11/11) |
Gene scanning analysis | 94% (16/17) | 91% (10/11) | 94% (16/17) | 91% (10/11) |
Heteroduplex analysis | 53% (8/17) | 100% (11/11) | 100% (8/8) | 55% (11/20) |